ANDREA RUIZ: Open Payments
NPI 1598197212 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,072 in 44 payments from 15 companies in 2025. Trend: 2023 $333 · 2024 $817 · 2025 $1,072
Food & beverage: $1,072
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $208 |
| Inspire Medical Systems, Inc. | 3 | $185 |
| Lilly USA, LLC | 3 | $159 |
| GlaxoSmithKline, LLC. | 2 | $137 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $101 |
| Amgen Inc. | 5 | $79 |
| Exact Sciences Corporation | 2 | $40 |
| Merck Sharp & Dohme LLC | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $28 |
| Janssen Biotech, Inc. | 1 | $21 |
Products named: INSPIRE, SHINGRIX, ZEPBOUND, Kerendia, Wegovy, OTEZLA, Ozempic, MOUNJARO.
Industry payments across NJ — which companies pay providers there.
